SBN 0.00% 0.0¢ sun biomedical limited

action, page-6

  1. 1,963 Posts.
    lightbulb Created with Sketch. 25
    SBN has defended its patents successfully in the past as indicated in announcement below in 2008.

    Avitar Litigation
    As advised in the April 2008 investor update a settlement of the claim against Avitar has now been
    agreed upon, the terms of which are confidential. Although no cash amount was involved, the Board
    believes that the outcome of this settlement was positive for SBN as, under the terms of the settlement,
    Avitar has acknowledged the validity of SBNs patents (US patent nos. 6,046,058, 5,962,336,
    6,372,516, 7,041,253 and 7,300,627) and that Avitar does not own, or claim to own, any right, title,
    ownership interest, or any other interest in these patents, and that SBN has licensed the use of these
    patents to Avitar.

    KENS
 
watchlist Created with Sketch. Add SBN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.